Glioma-Derived Thrombospondin-1 Modulates Cd14+ Cell Tolerogenic Properties

REFERENCES

• Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS. The epidemiology of glioma in adults: a “state of the science” review. Neuro Oncol 2014;16:896–913.
   PubMed Web of Science ®Google Scholar
• Shields LBE, Choucair AK. Management of low-grade gliomas: a review of patient-perceived quality of life and neurocognitive outcome. World Neurosurg 2014;82:e299–e309.
   PubMed Web of Science ®Google Scholar
• Huse JT, Wallace M, Aldape KD, Berger MS, Bettegowda C, Brat DJ, Cahill DP, Cloughesy T, Haas-Kogan DA, Marra M, Miller CR, Nelson SJ, Salama SR, Soffietti Wen PY, Yip S, Yen K, Costello JF, Chang S. Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) Low-grade Glioma Research Workshop. Neuro Oncol 2014;16:173–178.
   PubMed Web of Science ®Google Scholar
• Kohanbash G, Okada H. Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development. Immunol Invest 2012;41:658–679.
   PubMed Web of Science ®Google Scholar
• Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol 2014;133:621–631.
   PubMed Web of Science ®Google Scholar
• Raverdeau M, Mills KHG. Modulation of T cell and innate immune responses by retinoic acid. J Immunol 2014;192:2953–2958.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ma Y, Fang Y, Wu S, Liu L, Fu D, Shen X. Regulatory T cell: a protection for tumour cells. J Cell Mol Med 2012;16:425–436.
   PubMed Web of Science ®Google Scholar
• Eguizabal C, Zenarruzabeitia O, Monge J, Santos S, Vesga MA, Maruri N, Arrieta A, Riñón M, Tamayo-Orbegozo L, Larrucea S, Borrego F. Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspective. Front Immunol 2014;5:439.
   PubMed Web of Science ®Google Scholar
• Faveeuw C, Trottein F. Optimization of natural killer T cell-mediated immunotherapy in cancer using cell-based and nano-vector vaccines. Cancer Res 2014;74:1632–1638.
   PubMed Web of Science ®Google Scholar
• Cook J, Hagemann T. Tumour-associated macrophages and cancer. Curr Opin Pharmacol 2013;13:595–601.
   PubMed Web of Science ®Google Scholar
• Mao Y, Poschke I, Kiessling R. Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells. J Intern Med 2014;276:154–170.
   PubMed Web of Science ®Google Scholar
• Leveson-Gower DB, Sega EI, Kalesnikoff J, Florek M, Pan Y, Pierini A, Galli SJ, Negrin RS. Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+regulatory T cells. Blood 2013;122:3659–3665.
   PubMed Web of Science ®Google Scholar
• Kurmaeva E, Bhattacharya D, Goodman W, Omenetti S, Merendino A, Berney S, Pizarro T, Ostanin DV. Immunosuppressive monocytes: possible homeostatic mechanism to restrain chronic intestinal inflammation. J Leukoc Biol 2014;96:377–389.
   PubMed Web of Science ®Google Scholar
• Gustafson MP, Lin Y, New KC, Bulur PA, O'Neill BP, Gastineau DA, Dietz AB. Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone. Neuro Oncol 2010;12:631–644.
   PubMed Web of Science ®Google Scholar
• Liang H, Yi L, Wang X, Zhou C, Xu L. Interleukin-17 facilitates the immune suppressor capacity of high-grade glioma-derived CD4 (+) CD25 (+) Foxp3 (+) T cells via releasing transforming growth factor beta. Scand J Immunol 2014;80:144–150.
   PubMed Web of Science ®Google Scholar
• Robertson IB, Rifkin DB. Unchaining the beast; insights from structural and evolutionary studies on TGFβ secretion, sequestration, and activation. Cytokine Growth Factor Rev 2013;24:355–372.
   PubMed Web of Science ®Google Scholar
• Bao J, Xiao J, Mao Y, Zheng XL. Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner. Arterioscler Thromb Vasc Biol 2014;34:397–407.
   PubMed Web of Science ®Google Scholar
• Tsuchida R, Osawa T, Wang F, Nishii R, Das B, Tsuchida S, Muramatsu M, Takahashi T, Inoue T, Wada Y, Minami T, Yuasa Y, Shibuya M. BMP4/Thrombospondin-1 loop paracrinically inhibits tumor angiogenesis and suppresses the growth of solid tumors. Oncogene 2014;33:3803–3811.
   PubMed Web of Science ®Google Scholar
• Gutierrez LS. The role of thrombospondin 1 on intestinal inflammation and carcinogenesis. Biomarker Insights 2008;3:171–178.
   PubMedGoogle Scholar
• Zhang HP, Wu Y, Liu J, Jiang J, Geng XR, Yang G, Mo L, Liu ZQ, Liu ZG, Yang PC. TSP1-producing B cells show immune regulatory property and suppress allergy-related mucosal inflammation. Sci Rep. 2013;3:3345.
   Google Scholar
• Seliger B, Massa C. The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape. Front Immunol 2013;4:419.
   Google Scholar
• Wang BQ, Zhang CM, Gao W, Wang XF, Zhang HL, Yang PC. Cancer-derived matrix metalloproteinase-9 contributes to tumor tolerance. J Cancer Res Clin Oncol 2011; 137:1525–1533.
   PubMed Web of Science ®Google Scholar
• Lindau D, Gielen P, Kroesen M, Wesseling P, Adema GJ. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology 2013;138:105–115.
   PubMed Web of Science ®Google Scholar
• Chen X, Song C-H, Feng B-S, Li T-L, Li P, Zheng P-Y, Chen X-M, Xing Z, Yang PC. Intestinal epithelial cell-derived integrin αβ6 plays an important role in the induction of regulatory T cells and inhibits an antigen-specific Th2 response. J Leukoc Biol 2011;90:751–759.
   PubMed Web of Science ®Google Scholar
• Zhang B HM, Zhang P, Cao H, Wang Y, Wang Z, Su T. BAFF promotes regulatory T-cell apoptosis and blocks cytokine production by activating B cells in primary biliary cirrhosis. Braz J Med Biol Res 2013;46:433–439.
   PubMed Web of Science ®Google Scholar
• Wilson TJ, Nannuru KC, Singh RK. Cathepsin G-mediated activation of pro-matrix metalloproteinase 9 at the tumor-bone interface promotes transforming growth factor-β signaling and bone destruction. Mol Cancer Res 2009;7:1224–1233.
   PubMed Web of Science ®Google Scholar
• Bailey DuBose K, Zayzafoon M, Murphy-Ullrich JE. Thrombospondin-1 inhibits osteogenic differentiation of human mesenchymal stem cells through latent TGF-β activation. Biochem Biophys Res Commun 2012;422:488–493.
   PubMed Web of Science ®Google Scholar
• Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006;24:99–146.
   PubMed Web of Science ®Google Scholar
• Muraoka-Cook RS, Kurokawa H, Koh Y, Forbes JT, Roebuck LR, Barcellos-Hoff MH, Moody SE, Chodosh LA, Arteaga CL. Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors. Cancer Res 2004;64:9002–9011.
   PubMed Web of Science ®Google Scholar
• Han S, Zhang C, Li Q, Dong J, Liu Y, Huang Y, Jiang T, Wu A. Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma. Br J Cancer 2014;110:2560–2568.
   PubMed Web of Science ®Google Scholar